Michael Kors (KORS) Hold Rating Maintained by Analysts at Piper Jaffray; The Price Objective is $34.0000; Arcadia Biosciences (RKDA) Shorts Increased By 27.52%

July 25, 2017 - By Dolores Ford

Among 28 analysts covering Michael Kors Holdings Ltd (NYSE:KORS), 4 have Buy rating, 2 Sell and 22 Hold. Therefore 14% are positive. Michael Kors Holdings Ltd has $65 highest and $26 lowest target. $44.05’s average target is 26.04% above currents $34.95 stock price. Michael Kors Holdings Ltd had 67 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, January 3 the stock rating was downgraded by PiperJaffray to “Neutral”. The firm has “Buy” rating given on Thursday, June 1 by Jefferies. Piper Jaffray downgraded Michael Kors Holdings Ltd (NYSE:KORS) on Friday, August 7 to “Underweight” rating. Oppenheimer maintained the shares of KORS in report on Wednesday, May 31 with “Hold” rating. Piper Jaffray maintained it with “Neutral” rating and $38 target in Monday, August 3 report. The rating was initiated by BB&T Capital on Thursday, July 30 with “Hold”. Canaccord Genuity maintained Michael Kors Holdings Ltd (NYSE:KORS) on Thursday, May 12 with “Hold” rating. The rating was maintained by Mizuho on Friday, July 31 with “Neutral”. The stock of Michael Kors Holdings Ltd (NYSE:KORS) earned “Hold” rating by RBC Capital Markets on Wednesday, July 5. The stock of Michael Kors Holdings Ltd (NYSE:KORS) has “Neutral” rating given on Friday, September 30 by Guggenheim.

Arcadia Biosciences Incorporated (NASDAQ:RKDA) had an increase of 27.52% in short interest. RKDA’s SI was 70,900 shares in July as released by FINRA. Its up 27.52% from 55,600 shares previously. With 14,300 avg volume, 5 days are for Arcadia Biosciences Incorporated (NASDAQ:RKDA)’s short sellers to cover RKDA’s short positions. The SI to Arcadia Biosciences Incorporated’s float is 0.2%. About 133,004 shares traded. Arcadia Biosciences Inc (NASDAQ:RKDA) has declined 43.32% since July 25, 2016 and is downtrending. It has underperformed by 60.02% the S&P500.

Analysts await Michael Kors Holdings Ltd (NYSE:KORS) to report earnings on August, 9. They expect $0.61 earnings per share, down 30.68% or $0.27 from last year’s $0.88 per share. KORS’s profit will be $94.25M for 14.32 P/E if the $0.61 EPS becomes a reality. After $0.73 actual earnings per share reported by Michael Kors Holdings Ltd for the previous quarter, Wall Street now forecasts -16.44% negative EPS growth.

Investors sentiment increased to 0.73 in 2016 Q4. Its up 0.01, from 0.72 in 2016Q3. It increased, as 60 investors sold Michael Kors Holdings Ltd shares while 163 reduced holdings. 41 funds opened positions while 121 raised stakes. 140.57 million shares or 0.70% less from 141.55 million shares in 2016Q3 were reported. Meiji Yasuda Asset Mgmt Ltd invested in 0.06% or 13,066 shares. Pitcairn invested in 22,502 shares or 0.12% of the stock. Cap Impact Advsr stated it has 0.23% of its portfolio in Michael Kors Holdings Ltd (NYSE:KORS). Commonwealth Of Pennsylvania Public School Empls Retrmt reported 9,415 shares stake. Proshare Advsr invested in 0.02% or 47,295 shares. Massachusetts-based Cadence Management Ltd Liability has invested 0.11% in Michael Kors Holdings Ltd (NYSE:KORS). Greystone Managed Invests has invested 0.29% in Michael Kors Holdings Ltd (NYSE:KORS). Huntington Bancorporation holds 0% of its portfolio in Michael Kors Holdings Ltd (NYSE:KORS) for 920 shares. Parkwood Ltd Liability Corp invested in 12,660 shares. Victory Inc holds 0% or 3,653 shares in its portfolio. Prtnrs Ltd Limited Liability Company has 73,744 shares. Finemark Natl Bank & holds 2,080 shares. 85,697 were accumulated by Franklin. Creative Planning has 0% invested in Michael Kors Holdings Ltd (NYSE:KORS) for 3,669 shares. Dearborn Llc holds 0.02% of its portfolio in Michael Kors Holdings Ltd (NYSE:KORS) for 5,442 shares.

About 3.25 million shares traded or 71.05% up from the average. Michael Kors Holdings Ltd (NYSE:KORS) has declined 10.54% since July 25, 2016 and is downtrending. It has underperformed by 27.24% the S&P500.

Michael Kors Holdings Limited is a designer, marketer, distributor and retailer of branded women’s apparel and accessories and men’s apparel bearing the Michael Kors tradename and related trademarks MICHAEL KORS, MICHAEL MICHAEL KORS, and various other related trademarks and logos. The company has market cap of $5.40 billion. The Firm operates through three divisions: retail, wholesale and licensing. It has a 10.72 P/E ratio. The Retail activities consist of collection stores and lifestyle stores, including concessions and outlet stores, located primarily in the Americas , Europe and Asia, as well as e-commerce.

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. As per Friday, July 21, the company rating was maintained by Piper Jaffray. As per Friday, May 12, the company rating was downgraded by PiperJaffray.

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The company has market cap of $24.79 million. The Firm develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It currently has negative earnings. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.